Skip to content

Kodiak Sciences Inc KOD Operating lease right-of-use asset amortization

Operating lease right-of-use asset amortization at other companies

Vera Therapeutics logo
Vera TherapeuticsVERA
Arcus Biosciences logo
Arcus BiosciencesRCUS
Roivant Sciences logo
Roivant SciencesROIV
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
Glaukos logo
GlaukosGKOS

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.32B+1,477%
Enterprise value$2.2B+2,798%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Reported directly by Kodiak Sciences Inc in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.

The official record: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kodiak Sciences Inc's operating lease right-of-use asset amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kodiak Sciences Inc's operating lease right-of-use asset amortization?
Kodiak Sciences Inc (KOD) reported operating lease right-of-use asset amortization of $2.23M in Q1 2026.
How has Kodiak Sciences Inc's operating lease right-of-use asset amortization changed year-over-year?
Kodiak Sciences Inc's operating lease right-of-use asset amortization increased by 5.0% year-over-year, from $2.13M to $2.23M.
What is the long-term trend for Kodiak Sciences Inc's operating lease right-of-use asset amortization?
Over 3 years (2022 to 2025), Kodiak Sciences Inc's operating lease right-of-use asset amortization has grown at a 3.5% compound annual growth rate (CAGR), from $7.21M to $7.99M.